Reaction #46141

ord-b0d616ffade642d8850dc2e3ab840ee7

Reaction equation

COc1ccc(C(=O)Cl)cc1
4-(methoxy)benzoyl chloride
COc1ccc2c(=O)n(C)c(CCNC(=O)C3(N)CC3)c(-c3ccccc3)c2c1.Cl
1-amino-N-[2-(6-methoxy-2-methyl-1-oxo-4-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl]cyclopropanecarboxamide hydrochloride
CCN(CC)CC
triethylamine
COc1ccc(C(=O)NC2(C(=O)NCCc3c(-c4ccccc4)c4cc(OC)ccc4c(=O)n3C)CC2)cc1
titled compound
COc1ccc(C(=O)NC2(C(=O)NCCc3c(-c4ccccc4)c4cc(OC)ccc4c(=O)n3C)CC2)cc1
4-Methoxy-N-[1-({[2-(6-methoxy-2-methyl-1-oxo-4-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl]amino}carbonyl)cyclopropyl]benzamide

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    Concentrationthe mixture was concentrated in vacuo
  2. 2
    OtherPurification by preparative reversed phase HPLC

Procedure

To a solution of 1-amino-N-[2-(6-methoxy-2-methyl-1-oxo-4-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl]cyclopropanecarboxamide hydrochloride (30 mg, 0.117 mmol) in 3 mL of dimethylformamide was added triethylamine (0.049 mL, 0.35 mmol), followed by 4-(methoxy)benzoyl chloride (24 mg, 0.14 mmol). After 3 days, the mixture was concentrated in vacuo. Purification by preparative reversed phase HPLC provided the titled compound. ESI+MS: 526.0 [M+H]+.

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07741322B2uspto-grants-2010_06